[Old and new positive inotropic drugs: problems and controversies].
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D000676:Amrinone; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005934:Glucagon / Q000627:therapeutic use; D005960:Glucosides / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007288:Inosine / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000631:Aminopyridines; D002316:Cardiotonic Agents; D005960:Glucosides; D007093:Imidazoles; D011799:Quinazolines; D014970:Xanthines; D007288:Inosine; D006632:Histamine; D005934:Glucagon; C040850:quazinone; C029758:sulmazole; D000676:Amrinone
Farmaci inotropi positivi vecchi e nuovi: problemi e controversie.